SecBot SecBot
8-K ·Filed Feb 24, 2026

INGN

Inogen Inc
BULLISH
Impact 7/10
Horizonweeks Processed8mo ago SEC0001193125-26-066968
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The combination of improved profitability, positive EBITDA turnaround, strong 2026 guidance, and a significant share repurchase program suggests improving fundamentals. Traders should monitor whether the company can sustain international growth and margin improvements while executing on its innovation pipeline.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
INGN ▲ +5.49% at T+60d
LONG call ✓ call won +5.49% · α vs SPY -1.46% · entry $6.01 → $6.34
Entry = T+0 close
Feb 24, 2026
via day close
T+1d
+7.15%
call +7.15% · α +7.70%
$6.44
settled 8mo ago
T+5d
+4.99%
call +4.99% · α +6.09%
$6.31
settled 8mo ago
T+20d
+6.82%
call +6.82% · α +12.06%
$6.42
settled 7mo ago
T+60d
+5.49%
call +5.49% · α -1.46%
$6.34
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Inogen reported full-year 2025 revenue growth of 3.9% to $348.7 million and significantly improved profitability with a net loss of $22.7 million (down from $35.9 million in 2024) and positive adjusted EBITDA of $2.7 million. The company guided for 6% revenue growth in 2026 and authorized a $30 million share repurchase program.

Key Financial Metrics

Revenue
$348.7M
+3.9% YoY
Adj. EPS
$-8.00
GAAP: $-2.27
Guidance
$366M-$373M
raised
Gross Margin
44.2%

Key Facts

  • Full-year 2025 revenue was $348.7 million, up 3.9% YoY
  • GAAP net loss improved to $22.7 million from $35.9 million in 2024
  • Adjusted EBITDA turned positive at $2.7 million in 2025 vs. -$9.5 million in 2024
  • 2026 revenue guidance is $366-$373 million (6% growth at midpoint)
  • Authorized $30 million share repurchase program
  • Cash, cash equivalents, marketable securities, and restricted cash totaled $120.9 million as of December 31, 2025, with no debt

Financial Impact

Revenue growth of 3.9% in 2025 with 6% expected growth in 2026, net loss reduced by $13.2 million year-over-year

revenueepsnet lossebitdacash

Segment Breakdown

SegmentRevenueGrowth
U.S. sales$156.5M-3.1%
International sales$138.8M+18.4%
U.S. rentals$53.4M-6.3%

Risk Factors

  • First quarter 2026 revenue expected to be flat due to lower U.S. rentals
  • Gross margin declined to 44.2% in 2025 from 46.1% in 2024 due to channel mix
  • U.S. sales and U.S. rentals both declined in 2025

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-066968
Document: ingn-20260220.htm0001193125-26-066968
Document: ingn-ex99_2.htm0001193125-26-066968
Document: 0001193125-26-066968-index-headers.html0001193125-26-066968
Document: 0001193125-26-066968-index.html0001193125-26-066968
Document: 0001193125-26-066968.txt0001193125-26-066968
3 reports for INGN
Performance horizon
Filters
Rows
Reports for INGN — sortable, filterable
TypeNow
Jun 11, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$6.40 $5.23▼ −18.28%▼ −21.55%$7.13 (+11.41%)
Apr 6, 2026
29w ago
8-K
NEUTRAL ★ 6/10
$6.80 $6.60▼ −2.94%▼ −16.21%$7.13 (+4.85%)
Feb 24, 2026
34w ago
8-K
BULLISH ★ 7/10
$6.01 $6.34▲ +5.49%▼ −1.46%$7.13 (+18.64%)
Showing 3 of 3

US Market Status

Market Closed — Opens Wed (17h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 24, 2026